Insider Transactions in Q4 2017 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q4 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2017
|
Fil LTD |
BUY
Conversion of derivative security
|
Indirect |
1,775,856
+16.21%
|
-
|
|
Dec 12
2017
|
Fil LTD |
BUY
Conversion of derivative security
|
Direct |
1,497,951
+16.22%
|
-
|
|
Dec 12
2017
|
Douglas K Bratton > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
275,000
+1.39%
|
$4,950,000
$18.0 P/Share
|
|
Dec 12
2017
|
Douglas K Bratton > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
19,986,798
+25.26%
|
-
|
|
Dec 12
2017
|
Flagship Ventures Fund V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
8,606,249
+49.11%
|
-
|